Berner, A., Bachmann, M., Bender, C., Pfeilschifter, J., Christen, U., & Mühl, H. (2016). Though Active on RINm5F Insulinoma Cells and Cultured Pancreatic Islets, Recombinant IL-22 Fails to Modulate Cytotoxicity and Disease in a Protocol of Streptozotocin-Induced Experimental Diabetes. Frontiers Media S.A.

Berner, Anika, Malte Bachmann, Christine Bender, Josef Pfeilschifter, Urs Christen, and Heiko Mühl. Though Active On RINm5F Insulinoma Cells and Cultured Pancreatic Islets, Recombinant IL-22 Fails to Modulate Cytotoxicity and Disease in a Protocol of Streptozotocin-Induced Experimental Diabetes. Frontiers Media S.A, 2016.

Berner, Anika, et al. Though Active On RINm5F Insulinoma Cells and Cultured Pancreatic Islets, Recombinant IL-22 Fails to Modulate Cytotoxicity and Disease in a Protocol of Streptozotocin-Induced Experimental Diabetes. Frontiers Media S.A, 2016.